Bing

SEARCH HISTORY

Oncomed Pharmaceuticals (OMED): I don't recommend spec biotech plays through the end of the year, said Cramer. The space is too hot. Humana (HUM): They posted a beautiful quarter, said Cramer. If the stock comes in, I'm a buyer. Transocean (RIG) …
CNBC · ByLee Brodie · 11/8/2013
The stock market can’t seem to get enough of biotech IPOs these days, and OncoMed Pharmaceuticals is the latest company to cash in. Redwood City, CA-based OncoMed Pharmaceuticals (NASDAQ: OMED) sold 4.8 million shares to IPO investors …
Xconomy · ByLuke Timmerman · 7/18/2013
OncoMed Pharmaceuticals, Inc. (OMED - Snapshot Report ... demcizumab for the treatment of patients suffering from first-line advanced-stage non-small cell lung cancer (NSCLC). The double-blinded, placebo-controlled, randomized phase II study (n=200 ...
ZACKS · 2/5/2015
More from Bing News
which resulted in its stock price tanking more than 27%. This triggered the momentum effect, and shares of Regado Biosciences (RGDO), OncoMed Pharmaceuticals, Inc. (OMED) and several other biotech stocks went down with it as well. Prana …
bidnessetc.com · 4/7/2014
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMED at http://www.zacks.com/ap/OMED Keywords: OncoMed Pharmaceuticals, Earnings …
Yahoo Singapore Finance · 3/12/2015
OncoMed intends to list its common stock on the Nasdaq under the symbol "OMED." Entities affiliated with GlaxoSmithKline LLC hold an 11.74 percent stake in OncoMed before the offering. The amount of money a company says it plans to raise in its first …
Reuters · 5/11/2012
New York, NY - (ACCESSWIRE) - 12/03/2013 - Equity Profile Report initiates its NASDAQ Active Stock Weekly Watch List adding Unilife Corporation (NASDAQ:UNIS - News), OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED - News), Medallion Financial …
Finance Yahoo · 12/3/2013
March 18, 2014 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing ... The number of shares outstanding of OncoMed's common stock as of March 11, 2014 was 29,480,494. Chief Financial …
GlobeNewswire · 3/18/2014
Analysts at Piper Jaffray initiated coverage on shares of OncoMed Pharmaceuticals (NASDAQ: OMED) with an “overweight” rating ... Oritani Financial's stock closed at $16.14 on Friday. Analysts at Exane BNP Paribas initiated coverage on shares of ...
Benzinga · ByLisa Levin · 8/12/2013
The stock market indices suffered another down day ... OncoMed Pharmaceuticals, Inc. (OMED) 2.72 to 24.12, and Retrophin, Inc. (RTRX) 2.89 to 15.36 included a small smattering of the biotech stocks on our board today. Twitter, Inc. was down 1.29 to ...
Forex Street · ByHarry Boxer · 4/14/2014